A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Shoulder Joint
Latest Information Update: 15 Mar 2024
At a glance
- Drugs Hyaluronic acid/triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Anika Therapeutics
- 09 Feb 2022 Status changed from recruiting to completed.
- 21 Jan 2021 Status changed from not yet recruiting to recruiting.
- 13 Jan 2021 Planned initiation date changed from 31 Dec 2020 to 31 Jan 2021.